What You Should Know:
– AppliedVR, a leader in immersive therapeutic solutions, has announced the launch of their flagship product, RelieVRx®, into the workers’ compensation market. This FDA-authorized virtual reality (VR) program is the first of its kind to offer comprehensive, non-pharmacological treatment for chronic lower back pain (CLBP
– AppliedVR’s RelieVRx® program signifies a significant advancement in pain management for workers’ compensation claims.
A Non-Pharmacological Approach to Pain Management
RelieVRx® stands out as the first comprehensive, immersive VR treatment specifically designed to address CLBP in workers’ compensation cases. This non-pharmaceutical pain therapy provides a cost-effective and convenient option for injured workers.
The RelieVRx device provides a safe and effective alternative to traditional pain management methods. Here’s what makes it unique:
- Immersive VR Experience: Patients learn valuable skills through a fully immersive VR experience, empowering them to actively manage and reduce their pain.
- Cost-Effective and Non-Pharmacological: RelieVRx offers a cost-effective solution without the use of medications, potentially reducing long-term healthcare costs.
- Clinically Proven Results: Studies have shown that RelieVRx leads to clinically significant reductions in pain intensity and its impact on daily activities, sleep, mood, and stress. These positive effects are sustained even two years after treatment completion.
Immersive Therapy from Home
Workers can utilize RelieVRx® from the comfort of their homes. The program features 56 interactive VR chapters, each approximately six minutes long. These sessions progressively build upon each other, promoting neuroplasticity – the brain’s ability to reorganize neural pathways associated with pain perception. AppliedVR’s innovative VR solution offers a safe, effective, and convenient option for reducing chronic lower back pain and improving overall well-being.
“The RelieVRx program is a safe and effective alternative to common treatment modalities without any of the risks that opioids and surgeries carry,” said AppliedVR’s Co-Founder and President Josh Sackman. “We believe this program will receive broad acceptance in the workers’ comp community.”
